" class="no-js "lang="en-US"> Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices
Sunday, March 26, 2023

Breaking News

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Celyad Oncology Appoints Georges Rawadi as Its New CEO Companion Spine Closes $60.1 Million Series A Funding Round EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

February 20 2023

Patrick Jeukenne, Aptar Pharma, On Drug Delivery Devices

In the video, Patrick Jeukenne, VP of Strategy Business Development & Marketing at Aptar Pharma, explains the importance of drug delivery devices in ensuring patients receive the correct dose of medication, and how innovation in the field is constantly improving the patient experience. Jeukenne explains the challenges involved in designing drug delivery devices that are user-friendly, easy to use, and safe for patients. He emphasizes the need for collaboration between various stakeholders, including patients, healthcare providers, and device manufacturers, to achieve these goals.

Jeukenne also discusses the potential of connected drug delivery devices, which can collect and transmit data about patients’ medication use to healthcare providers. This technology can improve medication adherence and patient outcomes, but also raises concerns about patient privacy and data security. Jeukenne emphasizes the importance of balancing the benefits of connected devices with these concerns.

Overall, Jeukenne’s discussion highlights the critical role that drug delivery devices play in modern healthcare, and the ongoing efforts to improve their design, functionality, and safety.

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

    Diseases

     Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO

    Appointments

     Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round

    Fundraising

     Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis

    News

     Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

    Appointments

     Read more
More On